Healthy men test updated version of EnliTuo® in safety study
NCT ID NCT07246291
First seen Nov 24, 2025 · Last updated May 15, 2026 · Updated 24 times
Summary
This study checks if a manufacturing change to the drug EnliTuo® affects how it works in the body. About 86 healthy men aged 18-45 will receive a single dose and be monitored for safety, drug levels, and immune response. The goal is to ensure the updated version is similar to the original.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY ADULT MALE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Shanghai Xuhui Central Hospital
Shanghai, China
Conditions
Explore the condition pages connected to this study.